Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1997-08-13
1999-09-28
Myers, Carla J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
435235, 435236, 536 231, 536 2372, 424816, C12N 700, C12N 704, C07H 2104, A61K 3912
Patent
active
059584246
ABSTRACT:
Recombinant genetic information (DNA or RNA), comprising a Chicken Anemia Virus (CAV)-specific nucleotide sequence and the use thereof for diagnostics, vaccination or protein production. Recombinant CAV protein and the use thereof for diagnostics, vaccination or production of CAV-specific antibodies. The use of CAV-specific antibodies thus obtained.
REFERENCES:
Orkin et al. Report and recommendations of the panel to assess the NIH investment in research on gene therapy, Dec. 1995.
De Boer Gerden F.
Noteborn Mathews H.M.
Leadd BV
Myers Carla J.
Rae-Venter Barbara
LandOfFree
Recombinant chicken anemia virus particle does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant chicken anemia virus particle, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant chicken anemia virus particle will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-700227